Weitz Investment Management reported 48 stock positions worth $1.4B in its 2026 Q2 Form 13F, for the quarter ended Jun 30, 2026, filed Aug 12, 2026. Its largest position is BERKSHIRE HATHAWAY INC (BRK.B), at 9.41% of the reported portfolio value. Its biggest move versus the previous quarter was in Veralto Corp (VLTO), where it increased the position by 93.8%.
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| BRK.B | BERKSHIRE HATHAWAY INC | 9.41% | 271,600 | TRIMMED (-2.6%) |
| GOOG | Alphabet Inc. | 6.56% | 268,100 | TRIMMED (-17.9%) |
| DHR | DANAHER CORP /DE/ | 6.46% | 489,500 | ADDED (+2.5%) |
| V | VISA INC. | 6.30% | 265,330 | HELD |
| MA | Mastercard Inc | 5.17% | 145,350 | TRIMMED (-1.1%) |
| AON | Aon plc | 4.91% | 213,860 | HELD |
| VMC | Vulcan Materials CO | 4.16% | 203,800 | TRIMMED (-4.9%) |
| META | Meta Platforms, Inc. | 4.02% | 102,960 | TRIMMED (-2.6%) |
| TMO | THERMO FISHER SCIENTIFIC INC. | 4.00% | 115,200 | TRIMMED (-4.8%) |
| IEX | IDEX CORP /DE/ | 3.97% | 252,400 | TRIMMED (-4.5%) |
| MSFT | MICROSOFT CORP | 3.96% | 153,200 | TRIMMED (-9.6%) |
| HEI.A | HEICO CORP | 3.65% | 204,479 | ADDED (+8.2%) |
| AMZN | AMAZON COM INC | 3.59% | 217,500 | TRIMMED (-2.2%) |
| TECH | BIO-TECHNE Corp | 2.66% | 543,200 | TRIMMED (-16.8%) |
| SIRI | SIRIUS XM HOLDINGS INC. | 2.43% | 1,188,000 | TRIMMED (-8.1%) |
| ADI | ANALOG DEVICES INC | 2.34% | 85,225 | TRIMMED (-19.9%) |
| EFX | EQUIFAX INC | 2.11% | 191,980 | ADDED (+2.3%) |
| LH | LABCORP HOLDINGS INC. | 1.92% | 99,050 | HELD |
| MLM | MARTIN MARIETTA MATERIALS INC | 1.89% | 47,370 | ADDED (+19.1%) |
| GPN | GLOBAL PAYMENTS INC | 1.76% | 350,000 | ADDED (+4.5%) |
| TXN | TEXAS INSTRUMENTS INC · ADR | 1.61% | 77,900 | TRIMMED (-51.3%) |
| IDXX | IDEXX LABORATORIES INC /DE | 1.29% | 35,300 | HELD |
| ACIW | ACI WORLDWIDE, INC. | 1.28% | 367,700 | HELD |
| PRM | Perimeter Solutions, Inc. | 1.11% | 450,817 | TRIMMED (-11.5%) |
| MELI | MERCADOLIBRE INC | 1.08% | 9,200 | ADDED (+15.0%) |
| ACN | Accenture plc | 1.03% | 119,700 | TRIMMED (-29.9%) |
| IR | Ingersoll Rand Inc. | 0.92% | 161,670 | ADDED (+21.4%) |
| CSGP | COSTAR GROUP, INC. | 0.83% | 423,181 | TRIMMED (-18.2%) |
| EEFT | EURONET WORLDWIDE, INC. | 0.81% | 160,000 | HELD |
| ASML | ASML HOLDING NV | 0.76% | 5,500 | HELD |
| LKQ | LKQ CORP | 0.74% | 408,000 | HELD |
| NFLX | NETFLIX INC | 0.73% | 147,200 | NEW |
| TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | 0.66% | 20,000 | HELD |
| ORCL | ORACLE CORP | 0.56% | 55,000 | HELD |
| COF | CAPITAL ONE FINANCIAL CORP | 0.56% | 40,000 | NEW |
| CRM | Salesforce, Inc. | 0.53% | 49,300 | TRIMMED (-39.5%) |
| NVDA | NVIDIA CORP | 0.48% | 35,000 | HELD |
| VLTO | Veralto Corp | 0.48% | 77,500 | ADDED (+93.8%) |
| RGEN | REPLIGEN CORP | 0.39% | 40,800 | ADDED (+60.0%) |
| LIN | LINDE PLC | 0.26% | 7,100 | TRIMMED (-1.4%) |
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | 0.23% | 2,550 | NEW |
| POOL | POOL CORP | 0.22% | 15,000 | HELD |
| SPGI | S&P Global Inc. | 0.20% | 7,150 | ADDED (+1.4%) |
| APH | AMPHENOL CORP /DE/ | 0.11% | 9,200 | HELD |
| FTV | Fortive Corp | 0.09% | 21,750 | TRIMMED (-3.3%) |
| FERG | Ferguson Enterprises Inc. /DE/ | 0.09% | 5,200 | HELD |
| CMCSA | COMCAST CORP | 0.08% | 47,000 | HELD |
| CHTR | CHARTER COMMUNICATIONS, INC. /MO/ | 0.01% | 650 | HELD |
The weights above sum to 98.4% of the fund’s reported 13F value. Only positions matched to a U.S.-listed ticker are listed; the remainder sits in unmatched or non-equity positions in the filing.
Exited this quarter: CDW, ODFL.
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 12, 2026. CIK 0000883965. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only and report holdings as of quarter-end; each filing is due within 45 days after quarter-end, so the filing lag above is the gap between quarter-end and this filing’s date, and it varies by when the manager actually filed.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Hypothetical 13F-clone performance — not the fund’s actual returns. The clone holds the long U.S. equity positions disclosed in this manager’s Form 13F filings at their reported weights, rebalanced on filing dates, on dividend-adjusted prices. Full series and the filing-by-filing evidence dossier: 13F-clone profile.
A snapshot at quarter-end, not today’s portfolio: 13F filings arrive up to 45 days late, cover long positions only, and omit cash, shorts, and derivatives. Copying this list also means copying its timing, prices, and position sizes.
Read the original filings at SEC EDGAR.
Not investment advice. Filings are delayed and incomplete.
How we measure: Methodology · Track Record · Q3 2026 13F tracker.
See the same rule applied to every tracked fund, including this one: Follow a Fund — each quarter’s top 5 new and increased positions, bought at the close on the first trading day after the 13F deadline and held for a quarter, scored against SPY.
Compare overlap → Compare your own book against this fund and the other tracked funds.
Flossbach von Storch · Track Record: how the signals scored · Compare overlap
One email a week: the week’s new filings and research. Subscribe free
← Wedgewood Partners · Whale Rock Capital Management →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.